
epinephrine (Adrenalin®)
Sympathomimetic
Epinephrine stimulates alpha, beta 1 and beta 2 adrenergic receptors in dose-related fashion. Rapid injection produces a rapid increase in blood pressure, ventricular contractility, and heart rate. In addition, epinephrine causes vasoconstriction in the arterioles of the skin and mucosa. It antagonizes the effects of histamine by decreasing its release and decreasing membrane permeability.
(SQ) 5-10 minutes
(IV, ET) 1-2 minutes
5-10 minutes
Bronchoconstriction
Anaphylaxis
All forms of cardiac arrest
Profound symptomatic bradycardia
Hypersensitivity
Hypovolemic shock
Coronary insufficiency
Hypertension
Headache, nausea, restlessness
Weakness, dysrhythmias, hypertension
Precipitation of angina pectoris
MAO inhibitors and bretylium may potentiate the effect of epinephrine
Beta adrenergic antagonists may blunt inotropic response.
Sympathomimetics and phosphodiesterase inhibitors may exacerbate dysrhythmia response.
May be deactivated by alkaline solutions (sodium bicarbonate, Furosemide)
1mg/ml (1:1,000)
0.1mg/ml (1:10,000) ampule and prefilled syringes
1mg IV or 2 2 ½ times the IV dose via ET, repeat every 3-5 minutes.
Initial Dose:
Repeat Doses:
Moderate allergice reaction/bronchoconstriction
Anaphylaxis (Severe allergic reaction)
Moderate allergice reaction/bronchoconstriction
Anaphylaxis (Severe allergic reaction)
2-10 mcg/min titrated to increased HR/BP
Suggested concentration: mix 1 mg in 500 ml solution to get 2 mcg/ml concentration
0.1 mcg/kg/min titrated to increase HR/BP
Suggested concentration: mix 0.6 mg/kg to create a 100 ml solution.
Pregnancy Safety: Category C
Do not use prefilled syringes for epinephrine infusions
Syncope has occurred following epinephrine administration to asthmatic children.
May increase myocardial oxygen demand